Imaging COX-2 expression in cancer using PET/SPECT radioligands: current status and future directions (Q38182495)

30 August 2017

Imaging COX-2 expression in cancer using PET/SPECT radioligands: current status and future directions (English)

1 reference

30 August 2017

Christopher Cawthorne

object named as

C Cawthorne

3

0 references

author name string

A Pacelli

1

1 reference

PubMed ID

24470172

30 August 2017

J Greenman

2

1 reference

PubMed ID

24470172

30 August 2017

G Smith

4

1 reference

30 August 2017

18 December 2013

1 reference

Journal of Labelled Compounds and Radiopharmaceuticals

30 August 2017

1 reference

30 August 2017

57

1 reference

30 August 2017

317-322

1 reference

30 August 2017

4

1 reference

The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment

30 August 2017

1 reference

Prostaglandins and cyclooxygenases in glial cells during brain inflammation

21 January 2018

1 reference

Preferential up-regulation of heparanase and cyclooxygenase-2 in carcinogenesis of Barrett's oesophagus and intestinal-type gastric carcinoma

21 January 2018

1 reference

21 January 2018

Inflammation and cancer

1 reference

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

21 January 2018

1 reference

Cyclooxygenase-2 in oncogenesis

21 January 2018

1 reference

Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis

21 January 2018

1 reference

Systematic review and meta-analysis of COX-2 expression and polymorphisms in prostate cancer

21 January 2018

1 reference

Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203.

21 January 2018

1 reference

Maximal COX-2 immunostaining and clinical response to celecoxib and interferon alpha therapy in metastatic renal cell carcinoma

21 January 2018

1 reference

Impact of celecoxib on capecitabine tolerability and activity in pretreated metastatic breast cancer: results of a phase II study with biomarker evaluation

21 January 2018

1 reference

COX2 expression predicts resistance to chemoradiotherapy in esophageal squamous cell carcinoma.

21 January 2018

1 reference

Synthesis and preliminary in vitro biological evaluation of new carbon-11-labeled celecoxib derivatives as candidate PET tracers for imaging of COX-2 expression in cancer

21 January 2018

1 reference

A general method for the synthesis of aryl [11C]methylsulfones: potential PET probes for imaging cyclooxygenase-2 expression

21 January 2018

1 reference

Evaluation of [(11)C]rofecoxib as PET tracer for cyclooxygenase 2 overexpression in rat models of inflammation

21 January 2018

1 reference

Radiosynthesis and evaluation of 11C-labeled diaryl-substituted imidazole and indole derivatives for mapping cyclooxygenase-2.

21 January 2018

1 reference

Synthesis and in vivo evaluation of [18F]-4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide as a PET imaging probe for COX-2 expression.

21 January 2018

1 reference

Synthesis of 4-(5-[18F]fluoromethyl-3-phenylisoxazol-4-yl)benzenesulfonamide, a new [18F]fluorinated analogue of valdecoxib, as a potential radiotracer for imaging cyclooxygenase-2 with positron emission tomography

21 January 2018

1 reference

Fluorinated COX-2 inhibitors as agents in PET imaging of inflammation and cancer

21 January 2018

1 reference

Radiosynthesis of a ¹⁸F-labeled 2,3-diarylsubstituted indole via McMurry coupling for functional characterization of cyclooxygenase-2 (COX-2) in vitro and in vivo.

21 January 2018

1 reference

A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes

21 January 2018

1 reference

Synthesis and cyclooxygenase inhibition of various (aryl-1,2,3-triazole-1-yl)-methanesulfonylphenyl derivatives

21 January 2018

1 reference

Synthesis and evaluation of radioiodinated cyclooxygenase-2 inhibitors as potential SPECT tracers for cyclooxygenase-2 expression.

21 January 2018

1 reference

Synthesis and evaluation of a radioiodinated lumiracoxib derivative for the imaging of cyclooxygenase-2 expression

21 January 2018

1 reference

[I]-Celecoxib Analogues as SPECT Tracers of Cyclooxygenase-2 in Inflammation

21 January 2018

1 reference

Clinical use and pharmacological properties of selective COX-2 inhibitors

21 January 2018

1 reference

Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition

21 January 2018

1 reference

Selecting Potential Targetable Biomarkers for Imaging Purposes in Colorectal Cancer Using TArget Selection Criteria (TASC): A Novel Target Identification Tool

21 January 2018

1 reference

PET imaging of patients with non-small cell lung cancer employing an EGF receptor targeting drug as tracer.

21 January 2018

1 reference

Synthesis and evaluation of fluorobenzoylated di- and tripeptides as inhibitors of cyclooxygenase-2 (COX-2)

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JLCR.3160

1 reference

30 August 2017

1 reference

PubMed ID

24470172